RNAZ
TRANSCODE THERA (RNAZ)
NASDAQ
$4.93-$0.36 (-6.72%)
Price as of Jun 03, 2026 7:14 PM EDT
  • $4.9M
    Market Cap
  • -24.77%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-13.4M
+38.28%
-9.7M
-20.85%
-12.3M
+19.85%
-10.2M
+271.55%
Depreciation and Amortization Expense
76,446
-15.90%
90,894
-26.39%
123,483
+25.23%
98,606
+132.18%
Total Operating Expenses
28.0M
+78.66%
15.7M
-19.35%
19.4M
+4.03%
18.7M
+203.45%
Operating Profit
-28.0M
+78.66%
-15.7M
-19.35%
-19.4M
+4.03%
-18.7M
+203.45%
Interest Income
79,198
+11,478.65%
684
-87.06%
5,285
-74.11%
20,410
+2,973.80%
Interest Expense
N/A
N/A
-26,813
-52.03%
-55,899
-41.20%
-95,070
0.00%
Interest Income and Expense and Net
79,198
+403.10%
-26,129
-48.38%
-50,614
-32.21%
-74,660
-20.92%
Total Nonoperating Income and Expense
-6.5M
+489.88%
-1.1M
-225.43%
872,421
-20.75%
1.1M
+259.02%
Income before Taxes
-34.4M
+105.15%
-16.8M
-13.56%
-19.4M
+4.03%
-18.7M
+203.45%
Income Taxes
226,068
N/A
0
N/A
0
N/A
0
-100.00%
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-34.7M
+106.32%
-16.8M
-9.41%
-18.5M
+5.59%
-17.6M
+156.67%
Net Income from Continuing Operations Applicable to Common
-36.3M
+116.09%
-16.8M
-9.49%
-18.5M
+5.59%
-17.6M
+156.67%
Basic EPS and Net Income
-52.59
+11.56%
-47.14
-54.50%
-103.61
+7,574.81%
-1.35
+66.67%
Diluted EPS and Net Income
-52.59
+11.56%
-47.14
-54.50%
-103.61
+7,574.81%
-1.35
+66.67%
Basic Weighted Average Shares
689,713
+93.68%
356,115
+98.94%
179,006
-98.62%
13.0M
+54.02%
Diluted Weighted Average Shares
689,713
+93.68%
356,115
+98.94%
179,006
-98.62%
13.0M
+54.02%
Balance Sheet
Cash and Cash Equivalents
17.8M
+206.54%
5.8M
+109.97%
2.8M
-44.30%
5.0M
-76.14%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
17.8M
+206.54%
5.8M
+109.97%
2.8M
-44.30%
5.0M
-76.14%
Total Current Assets
22.0M
+209.92%
7.1M
+59.21%
4.5M
-39.62%
7.4M
-67.54%
Accumulated Depreciation
387,260
+24.60%
310,813
+18.03%
263,343
+88.29%
139,860
+239.02%
Property and Plant and Equipment and Net
370,681
+618.74%
51,574
-57.27%
120,707
-42.13%
208,581
+1.12%
Total Long-Term Assets
370,681
+618.74%
51,574
-57.27%
120,707
-42.13%
208,581
-51.54%
Total Assets
162.4M
+2,126.32%
7.3M
+41.10%
5.2M
-31.87%
7.6M
-66.92%
Income Taxes Payable
226,068
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
35,685
0.00%
Total Current Liabilities
3.5M
+26.06%
2.8M
-20.59%
3.5M
-19.71%
4.3M
+71.55%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
7.0M
+7.38%
6.5M
+16,983.38%
38,291
-95.75%
900,000
-77.83%
Total Liabilities
10.5M
+12.94%
9.3M
+163.91%
3.5M
-18.83%
4.3M
+71.55%
Retained Earnings
-97.9M
+54.84%
-63.2M
+36.16%
-46.4M
+66.54%
-27.9M
+170.45%
Total Stockholders Equity
10.3M
+611.98%
-2.0M
-223.03%
1.6M
-49.37%
3.2M
-84.12%
Total Shares Outstanding
916,968
-10.90%
1.0M
+64.01%
627,448
-95.17%
13.0M
+0.56%
Cash Flow
Cash from Operating Activities
-19.5M
+46.34%
-13.3M
-26.22%
-18.1M
+14.67%
-15.8M
+199.28%
Capital Expenditures
6,660
-69.39%
21,761
-38.89%
35,609
-64.72%
100,919
-60.40%
Cash from Investing Activities
-4,436
-79.61%
-21,761
-38.89%
-35,609
-64.72%
-100,919
-59.92%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
31.5M
+92.20%
16.4M
+3.09%
15.9M
+265,542.41%
5,989
-99.98%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-40.85%
-84.85%
-269.57%
-7.28%
-290.74%
+152.64%
-115.08%
N/A
Return on Equity
-833.53%
-109.38%
8,890.77%
+1,270.07%
-759.85%
+411.44%
-148.57%
N/A
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
6.29
+145.85%
2.56
+100.49%
1.28
-24.81%
1.70
N/A
Cash Ratio
5.10
+143.17%
2.10
+164.41%
0.79
-30.62%
1.14
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow